The quadrivalent HPV vaccine is protective against genital warts: A meta-analysis

Anita Lukács, Zsuzsanna Máté, Nelli Farkas, Alexandra Mikó, Judit Tenk, Péter Hegyi, Balázs Németh, László Márk Czumbel, Sadaeng Wuttapon, István Kiss, Zoltán Gyöngyi, Gábor Varga, Zoltán Rumbus, Andrea Szabó

Research output: Contribution to journalArticle


Background: The quadrivalent human papillomavirus (HPV) vaccine has been assumed to give protection against genital warts (GW) as well as cervical cancer. Our main question was whether HPV vaccine has any effects on the prevention of GW reported in randomised controlled clinical trials (RCTs) and time-trend analyses. Methods: This meta-analysis was performed according to the PRISMA guidelines using the PICO format. We searched in three electronic databases (PubMed, Embase, Cochrane Trials), and assessed heterogeneity using the Q-test and I-squared statistics, meta-regression was also performed. Odds ratios (OR) and their confidence intervals (CI) were calculated. The sensitivity was tested by leave-one-out method. We evaluated the presence of publication bias using the funnel plot graph and the Copas selection model. The strength of evidence was assessed using the GRADE approach. Results: Eight RCTs (per-protocol populations) and eight time-trend ecological studies were included in this meta-analysis. A significant reduction (pooled OR = 0.03, 95% CI: 0.01-0.09; I-squared = 53.6%) of GW in young women was recorded in RCTs, and in time-trend analyses both in young women (pooled OR = 0.36, CI 95% = 0.26-0.51; I-squared = 98.2%), and in young men (pooled OR = 0.69, 95% CI = 0.61-0.78; I-squared = 92.7%). In subgroup analysis, a significant reduction of the number of GW events was observed especially in women under 21 years (pooled OR = 0.33, 95% CI = 0.17-0.63). Leave-one-out analysis showed that similar results could be obtained after excluding one study, meta-regression did not show significant difference. Conclusions: Prophylactic, quadrivalent HPV vaccination can prevent GW in healthy women and men, therefore, it should be included in routine immunization programme.

Original languageEnglish
Article number691
JournalBMC public health
Issue number1
Publication statusPublished - May 28 2020


  • Genital wart
  • Human papillomavirus
  • Prevention
  • Vaccination

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'The quadrivalent HPV vaccine is protective against genital warts: A meta-analysis'. Together they form a unique fingerprint.

  • Cite this

    Lukács, A., Máté, Z., Farkas, N., Mikó, A., Tenk, J., Hegyi, P., Németh, B., Czumbel, L. M., Wuttapon, S., Kiss, I., Gyöngyi, Z., Varga, G., Rumbus, Z., & Szabó, A. (2020). The quadrivalent HPV vaccine is protective against genital warts: A meta-analysis. BMC public health, 20(1), [691].